159 related articles for article (PubMed ID: 10404354)
1. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Pitt B; Poole-Wilson P; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
[TBL] [Abstract][Full Text] [Related]
2. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
5. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
Cowley AJ; Wiens BL; Segal R; Rich MW; Santanello NC; Dasbach EJ; Pitt B;
Qual Life Res; 2000; 9(4):377-84. PubMed ID: 11131930
[TBL] [Abstract][Full Text] [Related]
6. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J
Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ
Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J;
Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure.
Dasbach EJ; Rich MW; Segal R; Gerth WC; Carides GW; Cook JR; Murray JF; Snavely DB; Pitt B
Cardiology; 1999; 91(3):189-94. PubMed ID: 10516413
[TBL] [Abstract][Full Text] [Related]
12. Losartan: a review of its use, with special focus on elderly patients.
Simpson KL; McClellan KJ
Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
[TBL] [Abstract][Full Text] [Related]
13. Comparison of losartan and captopril in ELITE II.
Hall A
Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022946
[No Abstract] [Full Text] [Related]
14. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
15. Comparison of losartan and captopril in ELITE II.
Meyer FP
Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
[No Abstract] [Full Text] [Related]
16. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
17. Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure?
Trojian TH; Jackson EA
J Fam Pract; 2000 Aug; 49(8):759-60. PubMed ID: 10947144
[No Abstract] [Full Text] [Related]
18. Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.
Berry C; Norrie J; McMurray JJ
Am J Cardiol; 2001 Mar; 87(5):606-7, A9. PubMed ID: 11230847
[TBL] [Abstract][Full Text] [Related]
19. Comparison of losartan and captopril in ELITE II.
Lye M
Lancet; 2000 Sep; 356(9232):852; author reply 852-3. PubMed ID: 11022949
[No Abstract] [Full Text] [Related]
20. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
